Cargando…
Assessing Boron-Pleuromutilin AN11251 for the Development of Antibacterial Agents
Pleuromutilins are a group of antibiotics derived from the naturally occurring compound. The recent approval of lefamulin for both intravenous and oral doses in humans to treat community-acquired bacterial pneumonia has prompted investigations in modifying the structure to broaden the antibacterial...
Autores principales: | Han, Ming-Jie, Pan, Miaomiao, Xiao, Genhui, Yuan, Ying, Chen, Shawn, Zou, Zhiyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302868/ https://www.ncbi.nlm.nih.gov/pubmed/37375183 http://dx.doi.org/10.3390/molecules28124628 |
Ejemplares similares
-
In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis
por: Ehrens, Alexandra, et al.
Publicado: (2020) -
Synthesis and Biological Evaluation of New Pleuromutilin Derivatives as Antibacterial Agents
por: Shang, Ruo-Feng, et al.
Publicado: (2014) -
Discovery of Novel Pleuromutilin Derivatives as Potent Antibacterial Agents for the Treatment of MRSA Infection
por: Fang, Han-Qing, et al.
Publicado: (2022) -
Boron-Pleuromutilins
as Anti-Wolbachia Agents with Potential
for Treatment of Onchocerciasis and Lymphatic
Filariasis
por: Jacobs, Robert T., et al.
Publicado: (2019) -
Design, synthesis, biological evaluation and molecular docking study of novel pleuromutilin derivatives containing substituted benzoxazole as antibacterial agents
por: Ren, Jie, et al.
Publicado: (2023)